Sign in

CIK 0000879407 · Large accelerated filer

ARROWHEAD PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ARWR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
460408024
Phone
626-696-4702
Business address
177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
Former names
ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. SCHEDULE 13G Stake Statement of Beneficial Ownership
  4. SCHEDULE 13G Stake Statement of Beneficial Ownership
  5. SCHEDULE 13G Stake Statement of Beneficial Ownership
  6. 4 Planned sale Chief Financial Officer sold 13,095 shares at an average $71.35 ($934,285)
  7. 4 Planned sale Chief Medical Officer sold 10,000 shares at $75.00 ($750,000)
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. 144 Insider Sale of Securities
  10. 144 Insider Sale of Securities
  11. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  12. 8-K Event Shareholder vote results
  13. 4 Planned sale Chief Medical Officer sold 10,000 shares at $64.19 ($641,900)
  14. 144 Insider Sale of Securities
  15. 10-Q Report Quarterly Report
  16. 8-K Event Results of operations
  17. ARS Other Annual Report to Security Holders
  18. DEFA14A Proxy Proxy Materials
  19. DEF 14A Proxy Proxy Statement
  20. SCHEDULE 13G/A Stake Statement of Beneficial Ownership

Page 2 of 69 · 1,361 filings